Asia stocks tumble as hawkish Fed rattles tech; BOJ in focus

Focus was now on the conclusion of a Bank of Japan meeting later in the day, with analysts split over whether the bank will hike or hold rates. 

Regional stocks tracked an overnight tumble on Wall Street after the Fed cut rates by 25 basis points as expected, but flagged a substantially slower pace of rate cuts in the coming year.

Tech stocks bore the brunt of losses, as investors locked-in profits from a recent run-up in the sector. The NASDAQ Composite slid 3.6% in its worst day in nearly five months.

U.S. stock index futures were flat in Asian trade. 

Japan’s Nikkei 225 fell 1.2%, while the broader TOPIX lost 0.7% on weakness in heavyweight technology stocks.

Investors were cautious towards Japanese markets in anticipation of the BOJ, with analysts split over the central bank’s next move. 

A Reuters report showed policymakers were more geared towards a hold in December, but were actively considering rate hikes amid some resilience in Japan’s economy and a recent uptick in inflation. 

The BOJ had raised rates twice earlier in 2024, marking a historic shift away from nearly a decade of ultra-loose monetary policy. Governor Kazuo Ueda has also signaled that the central bank will raise rates further. 

Tech-heavy bourses were by far the worst performers in Asia, tracking steep overnight declines in their U.S. peers.

South Korea’s KOSPI index slid 1.7%, with sentiment towards the country remaining fragile amid increased political turmoil after President Yoon Suk Yeol was impeached over an unsuccessful attempt to impose military rule. 

Memory chip making giants SK Hynix Inc (KS:000660) and Samsung Electronics Co Ltd (KS:005930) were the biggest weights on the KOSPI, losing 3.8% and 2.7%, respectively. The two tracked a 16% slump in U.S. peer Micron Technology Inc (NASDAQ:MU), after the chipmaker’s quarterly revenue guidance largely missed expectations. The miss raised questions over just how resilient artificial intelligence demand remained, especially amid growing global economic headwinds.

Losses in tech and chipmaking stocks pulled Hong Kong’s Hang Seng index down 1%. 

Chinese markets also retreated, with the Shanghai Shenzhen CSI 300 and Shanghai Composite indexes losing 0.4% and 0.7%, respectively. But bigger losses in Chinese stocks were mitigated by optimism over Beijing’s plans for more fiscal spending in 2025.

Australia’s ASX 200 fell 1.8%, while Singapore’s Straits Times Index lost 0.2%. 

Futures for India’s Nifty 50 index pointed to a mildly positive open, with the index set for some relief after clocking three days of steep losses. 

Related Posts

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Warner Bros. Discovery, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WBD

New York, New York–(Newsfile Corp. – December 18, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Warner Bros. Discovery, Inc. (NASDAQ:…

Read more

Corruption may have disrupted Chinese military modernization goals, Pentagon report says

WASHINGTON (Reuters) -Corruption in China’s military may have disrupted its progress towards its 2027 military modernization goals, the Pentagon said in its annual report on Beijing’s military that was released…

Read more

Investors react to BOJ’s decision to keep rates steady

As widely expected, the nine-member BOJ board decided to keep its short-term policy rate unchanged at 0.25%. But hawkish board member Naoki Tamura dissented and proposed raising interest rates to…

Read more

Dollar rallies broadly, yen turns lower after BOJ holds

SINGAPORE (Reuters) -The dollar flirted with a two-year peak on Thursday after the Federal Reserve signalled a slower pace of rate cuts in 2025, while the yen blipped lower after…

Read more

Apple in talks with Tencent, ByteDance to roll out AI features in China, sources say

BEIJING (Reuters) – Apple (NASDAQ:AAPL) is in talks with Tencent and TikTok owner ByteDance about integrating their artificial intelligence models into iPhones sold in China, according to three sources familiar…

Read more

Caliway to Present CBL-514 Phase 2b Study Results for Subcutaneous Fat Reduction at IMCAS 2025 in Paris

The findings from the CBL-0204 Phase 2b clinical trial have been selected for presentation at IMCAS, the premier global congress in aesthetic medicine. The data will be highlighted in both…

Read more

Leave a Reply